Prophylaxis of hepatic encephalopathy in acute variceal bleed: A randomized controlled trial of lactulose versus no lactulose

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue 6, 2011, Pages 996-1003

  Sharma, Praveen ^a   Agrawal, Amit ^a   Sharma, Barjesh C ^a   Sarin, Shiv K ^a  

^a G B PANT HOSPITAL   (India)

Author keywords

Acute variceal bleed; Hepatic encephalopathy; Lactulose

Indexed keywords

AMMONIA; BILIRUBIN; LACTULOSE;

ACUTE DISEASE; ADULT; AMMONIA BLOOD LEVEL; ARTICLE; BLOATING; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEHYDRATION; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; ESOPHAGOSCOPY; ESOPHAGUS VARICES BLEEDING; FATALITY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; MALE; OUTCOME ASSESSMENT; POTASSIUM BLOOD LEVEL; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; RISK REDUCTION; SCORING SYSTEM; SIDE EFFECT; SODIUM BLOOD LEVEL; TASTE DISORDER; TREATMENT DURATION;

EID: 79955913770     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06596.x     Document Type: Article

References (26)

1. Ferenci P, Lockwood A, Mullen K etal. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716-21.
2. Riordan SM, Williams R. Treatment of hepatic encephalopathy. N. Engl. J. Med. 1997; 337: 473-9.
3. Mas A. Hepatic encephalopathy: from pathophysiology to treatment. Digestion 2006; 73 (Suppl. 1): 86-93.
4. Conn HO, Leevy CM, Vlahcevic ZR etal. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology 1977; 72: 573-83.
5. Lanthier PL, Morgan MY. Lactitol in the treatment of chronic hepatic encephalopathy: an open comparison with lactulose. Gut 1985; 26: 415-20.
6. Riggio O, Balducci G, Ariosto F etal. Lactitol in prevention of recurrent episodes of hepatic encephalopathy in cirrhotic patients with portal-systemic shunt. Dig. Dis. Sci. 1989; 34: 823-9.
7. Morgan MY, Hawley KE. Lactitol versus lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double-blind, randomized trial. Hepatology 1987; 7: 1278-84.
8. Heredia D, Caballería J, Arroyo V etal. Lactitol versus lactulose in the treatment of acute portal systemic encephalopathy (PSE). A controlled trial. J. Hepatol. 1987; 4: 293-8.
9. Clausen MR, Mortensen PB. Lactulose, disaccharides and colonic flora. Drugs 1997; 53: 930-42.
10. Liu Q, Duan ZP, Ha DK etal. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 2004; 39: 1441-9.
11. Grace ND, Groszmann RJ, Garcia-Tsao G etal. Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology 1998; 28: 868-80.
12. Garcia-Tsao G, Sanyal AJ, Grace ND etal. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007; 46: 922-38.
13. Rolachon A, Zarski JP, Lutz JM etal. Is the intestinal lavage with a solution of mannitol effective in the prevention of post-hemorrhagic hepatic encephalopathy in patients with liver cirrhosis? Results of a randomized prospective study. Gastroenterol. Clin. Biol. 1994; 18: 1057-62.
14. Bockel R, Doffoel M. Whole-gut irrigation with mannitol in cirrhotic patients with gastro-intestinal bleeding. Changes in blood ammonia and amino acids levels. Nouv. Presse Med. 1981; 10: 33-6.
15. Champault G, Psalmon F, Patel JC. Post-haemorrhagic encephalopathy in cirrhosis. Prevention by digestive irrigation with 100mg/L mannitol. Nouv. Presse Med. 1978; 7: 2455-8.
16. Tromm A, Griga T, Greving I etal. Orthograde whole gut irrigation with mannite versus paromomycine+lactulose as prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial. Hepatogastroenterology 2000; 47: 473-7.
17. Micklefield GH, Schwegler U, Hüppe D etal. Orthograde intestinal irrigation with a mannitol solution in reducing hepatic encephalopathy in patients with liver cirrhosis and gastrointestinal hemorrhage. Z. Gastroenterol. 1989; 27: 374-7.
18. de Franchis R. Evolving consensus in portal hypertension report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J. Hepatol. 2005; 43: 167-76.
19. Butterworth RF. The neurobiology of hepatic encephalopathy. Semin. Liver Dis. 1996; 16: 235-44.
20. Cordoba J, Blei AT. Treatment of hepatic encephalopathy. Am. J. Gastroenterol. 1997; 92: 1429-39.
21. Van Thiel DH, Fagiuoli S, Wright HI etal. Gastrointestinal transit in cirrhotic patients: effect of hepatic encephalopathy and its treatment. Hepatology 1994; 19: 67-71.
22. Bass NM. Review article: the current pharmacological therapies for hepatic encephalopathy. Aliment. Pharmacol. Ther. 2007; 25 (Suppl. 1): 23-31.
23. De Preter V, Vanhoutte T, Huys G etal. Effect of lactulose and Saccharomyces boulardii administration on the colonic urea-nitrogen metabolism and the bifidobacteria concentration in healthy human subjects. Aliment. Pharmacol. Ther. 2006; 23: 963-74.
24. Sharma BC, Sharma P, Agrawal A etal. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo. Gastroenterology 2009; 137: 885-91.
25. Shawcross DL, Shabbir SS, Taylor NJ etal. Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology 2010; 51: 1062-9.
26. Cazzaniga M, Dionigi E, Gobbo G etal. The systemic inflammatory response syndrome in cirrhotic patients: relationship with their in-hospital outcome. J. Hepatol. 2009; 51: 475-82.